Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

Ibrahim, Lobna, DiazGranados, Nancy, Franco-Chaves, Jose, Brutsche, Nancy, Henter, Ioline D, Kronstein, Phillip, Moaddel, Ruin, Wainer, Irving, Luckenbaugh, David A, Manji, Husseini K, Zarate, Carlos A·2012·Neuropsychopharmacology

DOI 10.1038/npp.2011.338

Cited by (309)

Items 101–200 of 309

Ketamine and other potential glutamate antidepressants
Arpan Dutta, Shane McKie, J.F.W. Deakin · 2014 · Psychiatry Research
Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder
Duncan, Wallace C., Selter, Jessica, Brutsche, Nancy, Sarasso, Simone, Zarate, Carlos A. · 2013 · Journal of Affective Disorders
What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities
Stephani E Strasburger, P. M. Bhimani, J. H. Kaabe, J. T. Krysiak, D. L. Nanchanatt, Tiffany Nguyen, K. A. Pough, T. A. Prince, N. S. Ramsey, K. H. Savsani et al. · 2017 · Journal of Clinical Pharmacy and Therapeutics
Oral ketamine for the treatment of pain and treatment-resistant depression
Schoevers, Robert A., Chaves, Tharcila V., Balukova, Sonya M., Rot, Marije aan Het, Kortekaas, Rudie · 2016 · British Journal of Psychiatry
Ketamine as a Fast Acting Antidepressant: Current Knowledge and Open Questions
Giacomo Salvadore, Jaskaran B. Singh · 2013 · CNS Neuroscience & Therapeutics
Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant
Ballard, Elizabeth D., Luckenbaugh, David A., Richards, Erica M., Walls, Tessa L., Brutsché, Nancy E., Ameli, Rezvan, Niciu, Mark J., Vande Voort, Jennifer L., Zarate, Carlos A. · 2015 · Journal of Psychiatric Research
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion
Steven J. Pennybaker, Mark J. Niciu, David A. Luckenbaugh, Carlos A. Zarate · 2016 · Journal of Affective Disorders
Ketamine, Sleep, and Depression: Current Status and New Questions
Duncan, Wallace C., Zarate, Carlos A. · 2013 · Current Psychiatry Reports
Experimental medication treatment approaches for depression
D. Ionescu, George I. Papakostas · 2017 · Translational Psychiatry
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis
Medeiros, Gustavo C., Gould, Todd D., Prueitt, William L., Nanavati, Julie, Grunebaum, Michael F., Farber, Nuri B., Singh, Balwinder, Selvaraj, Sudhakar, Machado-Vieira, Rodrigo, Achtyes, Eric D. et al. · 2022 · Molecular Psychiatry
New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity
Huang, Yu-Jhen, Lane, Hsien-Yuan, Lin, Chieh-Hsin · 2017 · Neural Plasticity
Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales
Elizabeth D. Ballard, Julia S. Yarrington, Cristan Farmer, Marc S. Lener, Bashkim Kadriu, Níall Lally, Deonte Williams, Rodrigo Machado‐Vieira, Mark J. Niciu, Lawrence Park et al. · 2018 · Journal of Affective Disorders
Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
Anees Bahji, Carlos A. Zarate, Gustavo Héctor Vázquez · 2022 · Expert Opinion on Drug Safety
Is There Anything Really Novel on the Antidepressant Horizon?
James W. Murrough, Dennis S. Charney · 2012 · Current Psychiatry Reports
Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: Developing treatments using an integrated translational approach
Rodrigo Machado‐Vieira, Márcio Gerhardt Soeiro‐de‐Souza, Erica M. Richards, Antônio Lúcio Teixeira, Carlos A. Zarate · 2013 · The World Journal of Biological Psychiatry
Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administration
Zhou, ZhiQiang, Zhang, GuangFen, Li, XiaoMin, Liu, XiaoYu, Wang, Nan, Qiu, LiLi, Liu, WenXue, Zuo, ZhiYi, Yang, JianJun · 2015 · Molecular Neurobiology
The Mood Stabilizer Lithium Potentiates the Antidepressant-Like Effects and Ameliorates Oxidative Stress Induced by Acute Ketamine in a Mouse Model of Stress
Chi‐Tso Chiu, Lisa Scheuing, Guangping Liu, Hsiao‐Mei Liao, Gabriel R. Linares, Dora H. Lin, De‐Maw Chuang · 2015 · The International Journal of Neuropsychopharmacology
Antisuicidal response following ketamine infusion is associated with decreased nighttime wakefulness in major depressive disorder and bipolar disorder
Vande Voort, Jennifer L., Ballard, Elizabeth D., Luckenbaugh, David A., Bernert, Rebecca A., Richards, Erica M., Niciu, Mark J., Park, Lawrence T., Machado-Vieira, Rodrigo, Duncan, Wallace C., Zarate, Carlos A. · 2017 · The Journal of Clinical Psychiatry
Ketamine for Bipolar Depression: A Systematic Review
Anees Bahji, Carlos A. Zarate, Gustavo Héctor Vázquez · 2021 · The International Journal of Neuropsychopharmacology
Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications
Melvyn W. Zhang, Keith M. Harris, Roger Ho · 2016 · BMC Medical Ethics
Glutamate and depression: Reflecting a deepening knowledge of the gut and brain effects of a ubiquitous molecule
Adejoke Y. Onaolapo, Olakunle J. Onaolapo · 2021 · World Journal of Psychiatry
Factors Influencing the Cardiovascular Response to Subanesthetic Ketamine: A Randomized, Placebo-Controlled Trial
Thomas Liebe, Shijia Li, Anton Lord, Lejla Čolić, Anna Linda Krause, Anil Batra, Moritz Kretzschmar, Catherine M. Sweeney‐Reed, Gusalija Behnisch, Björn Hendrik Schott et al. · 2017 · The International Journal of Neuropsychopharmacology
Ketamine for the Treatment of Depression in Patients Receiving Hospice Care: A Retrospective Medical Record Review of Thirty-One Cases
Iglewicz, Alana, Morrison, Katherine, Nelesen, Richard A., Zhan, Tingting, Iglewicz, Boris, Fairman, Nathan, Hirst, Jeremy M., Irwin, Scott A. · 2015 · Psychosomatics
Clinical pain management: Current practice and recent innovations in research
Jing Wang, Lisa Doan · 2024 · Cell Reports Medicine
Structural connectivity and response to ketamine therapy in major depression: A preliminary study
Megha M. Vasavada, Amber M. Leaver, Randall T. Espinoza, Shantanu H. Joshi, Stephanie N. Njau, Roger P. Woods, Katherine L. Narr · 2015 · Journal of Affective Disorders
The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study
Baron Shopsin · 2012 · Acta Neuropsychiatrica
Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: A randomized controlled trial
Costi, Sara, Soleimani, Laili, Glasgow, Andrew, Brallier, Jess, Spivack, John, Schwartz, Jaclyn, Levitch, Cara F., Richards, Samantha, Hoch, Megan, Stade, Elizabeth C. et al. · 2019 · Neuropsychopharmacology
Ketamine’s Antidepressant Efficacy is Extended for at Least Four Weeks in Subjects with a Family History of an Alcohol Use Disorder
Mark J. Niciu, David A. Luckenbaugh, Dawn Flosnik Ionescu, Erica M. Richards, Jennifer L. Vande Voort, Elizabeth D. Ballard, Nancy E. Brutsché, Maura L. Furey, Carlos A. Zarate · 2014 · The International Journal of Neuropsychopharmacology
Characterizing the course of suicidal ideation response to ketamine
Elizabeth D. Ballard, Julia S. Yarrington, Cristan Farmer, Erica M. Richards, Rodrigo Machado‐Vieira, Bashkim Kadriu, Mark J. Niciu, Peixiong Yuan, Lawrence Park, Carlos A. Zarate · 2018 · Journal of Affective Disorders
Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
Mervin Chávez-Castillo, Victoria Núñez, Manuel Nava, Ángel Ortega, Milagros Rojas, Valmore Bermúdez, Joselyn Rojas · 2019 · Advances in Pharmacological Sciences
Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial
Elaheh Salardini, Atefeh Zeinoddini, Payam Mohammadinejad, Mohammad Reza Khodaie Ardakani, Nagmeh Zahraei, Atefeh Zeinoddini, Shahin Akhondzadeh · 2016 · Journal of Psychiatric Research
Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder
Wei Zheng, Yanling Zhou, Wei-Jian Liu, Chengyu Wang, Yanni Zhan, Han-Qiu Li, Lijian Chen, Ming D. Li, Yuping Ning · 2019 · Journal of Psychopharmacology
Pharmacotherapy: Ketamine and Esketamine.
Anna Feeney, G. Papakostas · 2023 · Psychiatric Clinics of North America
Anaesthesia for electroconvulsive therapy – new tricks for old drugs: a systematic review
Tobias Anker Stripp, Martin Balslev Jørgensen, Niels Vidiendal Olsen · 2017 · Acta Neuropsychiatrica
Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats
Rachel R. Horsley, Tomáš Páleníček, Jan Kolin, Karel Valeš · 2018 · Behavioural Pharmacology
Differential regulation of GluA1 expression by ketamine and memantine
Zhang, Ke, Yamaki, Vitor Nagai, Wei, Zhisheng, Zheng, Yu, Cai, Xiang · 2017 · Behavioural Brain Research
Does Ketamine Have Anti-Suicidal Properties? Current Status and Future Directions
Rebecca B. Price, Sanjay J. Mathew · 2015 · CNS Drugs
NMDA antagonists under investigation for the treatment of major depressive disorder
Bartłomiej Pochwat, Agnieszka Pałucha-Poniewiera, Bernadeta Szewczyk, Andrzej Pilc, Gabriel Nowak · 2014 · Expert Opinion on Investigational Drugs
A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder
Sanjay J. Mathew, Ralitza V. Gueorguieva, Cynthia Brandt, Maurizio Fava M. D, Gerard Sanacora · 2017 · Neuropsychopharmacology
An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine
Domenico De Berardis, Carmine Tomasetti, Maurizio Pompili, Gianluca Serafini, Federica Vellante, Michele Fornaro, Alessandro Valchera, Giampaolo Perna, Umberto Volpe, Giovanni Martinotti et al. · 2020 · Current Topics in Medicinal Chemistry
Whole blood transcriptional signatures associated with rapid antidepressant response to ketamine in patients with treatment resistant depression
Flurin Cathomas, Laura Bevilacqua, Aarthi Ramakrishnan, Hope Kronman, Sara Costi, Molly Schneider, Kenny L. Chan, Long Li, Eric J. Nestler, Li Shen et al. · 2022 · Translational Psychiatry
Ketamine for the Treatment of Depression
Robert H. Howland · 2013 · Journal of Psychosocial Nursing and Mental Health Services
Effects of a single subanaesthetic dose of ketamine on pain and mood after laparoscopic bariatric surgery
Jing Wang, Ghislaine C. Echevarría, Lisa Doan, Nydia Ekasumara, Steven Calvino, Floria E. Chae, Erik Martinez, Eric J. Robinson, Germaine E. Cuff, Lola Franco et al. · 2018 · European Journal of Anaesthesiology
Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder
Allison Carol Nugent, Stephen E. Robinson, Richard Coppola, Carlos A. Zarate · 2016 · Psychiatry Research Neuroimaging
Longitudinal two-photon imaging in somatosensory cortex of behaving mice reveals dendritic spine formation enhancement by subchronic administration of low-dose ketamine
Evgeny Pryazhnikov, Ekaterina Mugantseva, Plinio Cabrera Casarotto, Julia Kolikova, Senem Merve Fred, Dmytro Toptunov, Ramil A. Afzalov, Pirta Hotulainen, Vootele Võikar, Ryan T. Terry-Lorenzo et al. · 2018 · Scientific Reports
Ketamine: The final frontier or another depressing end?
Omar K. Sial, Eric M. Parise, Lyonna F. Parise, Tamara Gnecco, Carlos A. Bolaños‐Guzmán · 2020 · Behavioural Brain Research
A review on the recent application of ketamine in management of anesthesia, pain, and health care
Babak Hosseinzadeh Zoroufchi, Abolfazl Abdollahpour, Elham Saffarieh · 2020 · Journal of Family Medicine and Primary Care
Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner
Kristína Holubová, Lenka Kletečková, Martina Škurlová, Jan Říčný, Aleš Stuchlı́k, Karel Valeš · 2016 · Psychopharmacology
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
Sanne Y. Smith-Apeldoorn, Jolien K. E. Veraart, Jeanine Kamphuis, Antoinette D. I. van Asselt, Daan Johannes Touw, Marije aan het Rot, Robert A. Schoevers · 2019 · BMC Psychiatry
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Eric P. McMullen, Yena L. Lee, Orly Lipsitz, Leanna M.W. Lui, Maj Vinberg, Roger Ho, Nelson B. Rodrigues, Joshua Daniel Rosenblat, Bing Cao, Hartej Gill et al. · 2021 · Advances in Therapy
Efficacy of ketamine for major depressive episodes at 2, 4, and 6-weeks post-treatment: A meta-analysis
Conley, Ashley A., Norwood, Amber E. Q., Hatvany, Thomas C., Griffith, James D., Barber, Kathryn E. · 2021 · Psychopharmacology
Personalized use of ketamine and esketamine for treatment-resistant depression
Gustavo C. Medeiros, Isabella Demo, Fernando S. Goes, Carlos A. Zarate, Todd D. Gould · 2024 · Translational Psychiatry
Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice
Jen-Cheng Lin, Mei-Yi Lee, Ming‐Huan Chan, Yi-Chyan Chen, Hwei‐Hsien Chen · 2016 · Psychopharmacology
Subanesthetic Dose Ketamine Does Not Induce an Affective Switch in Three Independent Samples of Treatment-Resistant Major Depression
Mark J. Niciu, David A. Luckenbaugh, Dawn Flosnik Ionescu, Daniel C. Mathews, Erica M. Richards, Carlos A. Zarate · 2013 · Biological Psychiatry
Suicidality and Activation of the Kynurenine Pathway of Tryptophan Metabolism
Elena Y. Bryleva, Lena Brundin · 2016 · Current topics in behavioral neurosciences
Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression
Wei Guo, Rodrigo Machado‐Vieira, Sanjay J. Mathew, James W. Murrough, Dennis S. Charney, Matthew Grunebaum, María A. Oquendo, Bashkim Kadriu, Nirmala Akula, Ioline D. Henter et al. · 2018 · Translational Psychiatry
Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis
de Boer, J.N., Vingerhoets, C., Hirdes, M., McAlonan, G.M., Amelsvoort, T.V., Zinkstok, J.R. · 2019 · Psychiatry Research
Rapid-onset antidepressant efficacy of glutamatergic system modulators: The neural plasticity hypothesis of depression
Jing Wang, Liang Jing, Juan-Carlos Toledo-Salas, Lin Xu · 2014 · Neuroscience Bulletin
Current Status of Ketamine and Related Compounds for Depression
Daniel C. Mathews, Carlos A. Zarate · 2013 · The Journal of Clinical Psychiatry
Antidepressant-like effects induced by NMDA receptor blockade and NO synthesis inhibition in the ventral medial prefrontal cortex of rats exposed to the forced swim test
Vitor Silva Pereira, Angélica Caroline Dutra Romano Suavinha, Gregers Wegener, Sâmia R.L. Joca · 2015 · Psychopharmacology
Ketamine as Antidepressant? Current State and Future Perspectives
Helge Hasselmann · 2013 · Current Neuropharmacology
Ketamine‐An Update on Its Clinical Uses and Abuses
Jian Xu, Hong Lei · 2014 · CNS Neuroscience & Therapeutics
Rapid antidepressant effects: moving right along
Keri Martinowich, Dennisse V. Jimenez, Carlos A. Zarate, Husseini K. Manji · 2013 · Molecular Psychiatry
Has psychiatry tamed the “ketamine tiger?” Considerations on its use for depression and anxiety
Rasmussen, Keith G. · 2016 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Repurposing Potential of Ketamine: Opportunities and Challenges
C S Gautam, Sonia S. Mahajan, Jatin Sharma, Harmanjit Singh, Jagjit Singh · 2019 · Indian Journal of Psychological Medicine
Association between peripheral inflammation and free-water imaging in Major Depressive Disorder before and after ketamine treatment – A pilot study
Mina Langhein, Johanna Seitz‐Holland, Amanda E. Lyall, Ofer Pasternak, Natalia Chunga, Suheyla Cetin Karayumak, Antoni Kubicki, Christoph Mulert, Randall T. Espinoza, Katherine L. Narr et al. · 2022 · Journal of Affective Disorders
Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression
E. Drewniany, J. Han, C. Hancock, Rachel L. Jones, J. Lim, N. Nemat Gorgani, James Sperry, H. J. Yu, Robert B. Raffa · 2014 · Journal of Clinical Pharmacy and Therapeutics
Pharmacologic approaches to suicide prevention
Zisook, Sidney, Domingues, Isabel, Compton, Jason · 2023 · Focus
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M. Canuso, Jaskaran B. Singh, Maggie M Fedgchin, Larry D Alphs, Rosanne Lane, Pilar Lim, Christine Pinter, David W. Hough, Gerard Sanacora, Husseini K. Manji et al. · 2019 · FOCUS The Journal of Lifelong Learning in Psychiatry
Sex differences in ketamine's therapeutic effects for mood disorders: A systematic review
Katie C Benitah, Ashley N. Siegel, Orly Lipsitz, Nelson B. Rodrigues, Shakila Meshkat, Yena L. Lee, Rodrigo Barbachan Mansur, Flora Nasri, Leanna M.W. Lui, Roger S. McIntyre et al. · 2022 · Psychiatry Research
Differential effects of NMDA receptor antagonism on spine density
Rebecca M. Ruddy, Yuxiao Chen, Marija Milenkovic, Amy J. Ramsey · 2014 · Synapse
Ketamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on Efficacy
Basant Pradhan, Tapan Parikh, Ramkrishna D. Makani, Madhusmita Sahoo · 2015 · Depression Research and Treatment
Ketamine as a rapid antidepressant: the debate and implications
Roger Ho, Melvyn W. Zhang · 2016 · BJPsych Advances
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder
Mark J. Niciu, Nicolas D. Iadarola, Dipavo Banerjee, David A. Luckenbaugh, Minkyung Park, Marc S. Lener, Lawrence Park, Dawn Flosnik Ionescu, Elizabeth D. Ballard, Nancy E. Brutsché et al. · 2017 · Journal of Psychopharmacology
Riluzole likely lacks antidepressant efficacy in ketamine non-responders
Mark J. Niciu, David A. Luckenbaugh, Dawn Flosnik Ionescu, Erica M. Richards, Jennifer L. Vande Voort, Elizabeth D. Ballard, Nancy E. Brutsché, Maura L. Furey, Carlos A. Zarate · 2014 · Journal of Psychiatric Research
Investigation of antidepressant-like and anxiolytic-like actions and cognitive and motor side effects of four N-methyl-d-aspartate receptor antagonists in mice
Louise K. Refsgaard, Darryl S. Pickering, Jesper Tobias Andreasen · 2016 · Behavioural Pharmacology
Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders
Sara Costi, Nicholas T. Van Dam, James W. Murrough · 2015 · Current Behavioral Neuroscience Reports
The Black Book of Psychotropic Dosing and Monitoring
Charles DeBattista, Alan F. Schatzberg · 2025 · Psychopharmacology Bulletin
Neural Plasticity Is Involved in Physiological Sleep, Depressive Sleep Disturbances, and Antidepressant Treatments
Mengqi Zhang, Rui Li, Yi‐Qun Wang, Zhi‐Li Huang · 2017 · Neural Plasticity
Genetic variables of the glutamatergic system associated with treatment-resistant depression: A review of the literature
Estela Saez, Leire Erkoreka, Teresa Moreno-Calle, Belén Berjano, Ana María González-Pinto, Nieves Basterreche, Aurora Arrúe · 2022 · World Journal of Psychiatry
Clinical overview of NMDA-R antagonists and clinical practice
Pasha A Davoudian, S. T. Wilkinson · 2020 · Advances in Pharmacology
Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines
David J. Heal, Jane Gosden, Sharon L. Smith, C.K. Atterwill · 2022 · Neuropharmacology
Clinical Efficacy of Ketamine for Treatment-resistant Depression
Sosipatros Bratsos, Sohag Nafis Saleh · 2019 · Cureus
Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder
Patricia T. Spangler, James C. West, Catherine L. Dempsey, Kyle Possemato, Danielle Bartolanzo, Pablo A. Aliaga, Carlos A. Zarate, Meena Vythilingam, David M. Benedek · 2020 · The Journal of Clinical Psychiatry
Are 24-hour motor activity patterns associated with continued rapid response to ketamine?
Duncan Jr, Wallace C, Slonena, Elizabeth E, Hejazi, Nadia S, Brutsche, Nancy, Park, Lawrence T, Henter, Ioline D, Ballard, Elizabeth D, Zarate Jr, Carlos A · 2018 · Neuropsychiatric Disease and Treatment
Prospective association of psychological pain and hopelessness with suicidal thoughts
Ballard, Elizabeth D., Farmer, Cristan A., Gerner, Jessica, Bloomfield-Clagett, Bartholt, Park, Lawrence T., Zarate, Carlos A. · 2022 · Journal of Affective Disorders
The relationship between the HDRS insomnia items and polysomnographic (PSG) measures in individuals with treatment-resistant depression
Nadia S. Hejazi, Cristan Farmer, Mark Ryan Oppenheimer, Tolulope B. Falodun, Lawrence T. Park, Wallace C. Duncan, Carlos A. Zarate · 2022 · Journal of Psychiatric Research
Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system
Malika S. Datta, Yannan Chen, Shradha Chauhan, Jing Zhang, Estanislao Daniel De La Cruz, Cheng Gong, Raju Tomer · 2023 · Cell Reports
Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome
Jack D. C. Dahan, David Dadiomov, Tijmen Bostoen, Albert Dahan · 2024 · npj Mental Health Research
Mechanism of action of dextromethorphan/quinidine: comparison with ketamine
Stephen M. Stahl · 2013 · CNS Spectrums
A review of ketamine’s role in ECT and non-ECT settings
Vytautas Jankauskas, Candace Necyk, James Chue, Pierre S. Chue · 2018 · Neuropsychiatric Disease and Treatment
Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression
Steven J. Pennybaker, Brian J. Roach, Susanna L. Fryer, Anusha Badathala, Art Wallace, Daniel H. Mathalon, Tobias F. Marton · 2021 · Psychopharmacology
Combination therapy utilizing ketamine and transcranial magnetic stimulation for treatment-resistant depression: a case report
Steven Best, Brian Griffin · 2014 · International Journal of Neuroscience
Baseline Vitamin B12 and Folate Levels Do Not Predict Improvement in Depression After a Single Infusion of Ketamine
Nancy B. Lundin, Mark J. Niciu, David A. Luckenbaugh, D. Ionescu, Erica M. Richards, Jennifer Vande Voort, Nancy E. Brutsché, Rodrigo Machado‐Vieira, Carlos A. Zarate · 2014 · Pharmacopsychiatry
Subchronic administration of (R,S)-ketamine induces ketamine ring hydroxylation in Wistar rats
Ruin Moaddel, Mitesh Sanghvi, Anuradha Ramamoorthy, Krzysztof Jóźwiak, N. Singh, C. Green, Kathleen G. O’Loughlin, Marc C. Torjman, Irving W. Wainer · 2016 · Journal of Pharmaceutical and Biomedical Analysis
Effet antidépresseur de la kétamine : revue de la littérature sur l’utilisation de la kétamine dans la dépression
Pierre de Maricourt, Thérèse M. Jay, PEDRO SIMOES GONCALVES, H. Löo, Raphaël Gaillard B · 2014 · L Encéphale
Relapse prevention in treatment-resistant major depressive disorder with rapid-acting antidepressants
Jaskaran B. Singh, Maggie M Fedgchin, Ella Daly, Wayne Curtis Drevets · 2020 · Advances in pharmacology
Glutamatergic dysregulation in mood disorders: opportunities for the discovery of novel drug targets
Małgorzata Panek, Paweł Kawalec, Iwona Malinowska‐Lipień, Tomasz Brzostek, Andrzej Pilc · 2020 · Expert Opinion on Therapeutic Targets
Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions
Anna Onisiforou, Polymnia Georgiou, Panos Zanos · 2023 · Pharmacology Biochemistry and Behavior
Long-term outcomes of repeated ketamine infusions in patients with unipolar and bipolar depression: A naturalistic follow-up study
Weicheng Li, Yanling Zhou, Weijian Liu, Chengyu Wang, Xiaofeng Lan, Zhipei Zhang, Fan Zhang, Yanxiang Ye, Haiyan Liu, Kai Wu et al. · 2021 · Journal of Affective Disorders